Hepatitis B Core‐Related Antigen Level Predicts Disease Progression in the Gray Zone Hepatitis B Patients

Documenti analoghi

• Clinical performance of Circulating HBV RNA and iTACT‐HBcrAg Assays in HBeAg‐negative and HBsAg‐cleared Chronic Hepatitis B Patients
  di: Takanori Suzuki, et al.
  Pubblicazione: (2024)
• Factors associated with low hepatitis B surface antigen levels in chronic hepatitis B patients treated with nucleot(s)ide analogs
  di: Takanori Suzuki, et al.
  Pubblicazione: (2024)
• Fatal Hepatitis B Reactivation in Absence of Antibody to Hepatitis B Core Antigen in a Lymphoma Patient
  di: Solenn Klutsch, et al.
  Pubblicazione: (2025)
• Efficacy of antiviral therapy for the prevention of mother‐to‐child transmission of hepatitis B virus and the risk of postpartum hepatitis flare after discontinuation of antiviral therapy
  di: Hayato Kawamura, et al.
  Pubblicazione: (2024)
• Hepatitis B Virus Genomic Variability & HBV‐Related Disease Outcomes: A Molecular Epidemiology Perspective
  di: Maria Bousali, et al.
  Pubblicazione: (2025)